A phase III randomized study of nivolumab plus AVD or Brentuximab Vedotin plus AVD in patients age >=12 with newly diagnosed advanced stage classical Hodgkin Lymphoma.Read More
A phase II study of veliparib and local irradiation followed by maintenance veliparib and temozolomide in children with newly diagnosed high grade glioma (HGG).Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.